Trial · NCT01807065
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-free Survival | Arm A (Sipuleucel-T) | 2.46 | 95% Confidence Interval 2.17 to 2.66 | Months | |
| Progression-free Survival | Arm B (Radiation Therapy, Sipuleucel-T) | 3.65 | 95% Confidence Interval 2.76 to 4.86 | Months | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Chills | 3 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Chills | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Fatigue | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Fatigue | 2 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Infusion Reaction | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Infusion Reaction | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Decreased Lymphocyte Count | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Decreased Lymphocyte Count | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Nausea | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Nausea | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Pain in Extremity | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Pain in Extremity | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Anemia | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Anemia | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Anorexia | 0 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Anorexia | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm A (Sipuleucel-T) | Grade 2 : Headache | 1 | participants | |
| Number of Participants With Grade 2 or Above Adverse Events | Arm B (Radiation Therapy, Sipuleucel-T) | Grade 2 : Headache | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01807065/results